Tirzepatide (120 mg)
This product is coming soon and is not yet available for purchase.
All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
99% PURITY GUARANTEE
99% PURITY GUARANTEE
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.
Preparation & Handling Notice
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
RESEARCH USE ONLY
This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.
Strength: 120 mg
CAS: 2023788-19-2
Chemical Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight: 4813.48 g/mol
Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys(C20-linker)-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
Synonyms: P1206, LY3298176, tirzepatida, tirzepatidum, OYN3CCI6QE
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
Tirzepatide, also known as LY3298176 or P1206, is a synthetic dual receptor–targeted peptide supplied as a high-purity lyophilized powder for laboratory research. It is widely studied in metabolic and endocrine research models to investigate hormone receptor signaling, glucose regulation pathways, and energy balance mechanisms under controlled experimental conditions.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1–2 business days.
-
Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.
Why Choose NOVERA COMPOUNDS Peptides?
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
- High-purity, research-grade peptide synthesis
- Analytical testing to verify quality and composition
- Consistent batch-to-batch performance
- Batch identification on every vial for traceability
- Stored and shipped under controlled conditions
High-purity, research-grade peptide synthesis
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
What is Tirzepatide (120 mg)?
Tirzepatide is a synthetic peptide used in laboratory research to investigate metabolic signaling pathways related to nutrient response and energy regulation. It is often classified within incretin and metabolic peptide research due to its frequent use in models studying incretin-related receptor activity and downstream signaling mechanisms. In experimental settings, Tirzepatide is applied in receptor-binding studies, pathway analysis, and the comparative evaluation of peptide candidates.
Product Specifications
- Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum
- CAS Number: 2023788-19-2
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular Weight:4813.48 g/mol g/mol
- Peptide Sequence:
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ - Purity: ≥95% (verified by HPLC and mass spectrometry)
- Packaging Format: 120 mg lyophilized powder in a sealed research-grade vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long term). Protect from light.
- Intended Use: For Laboratory Research Use Only
Key Characteristics of Tirzepatide (120 mg)
- Defined peptide standard: Optimized for reproducible laboratory experiments and consistent results.
- High purity: ≥95%, minimizing variability in experimental outcomes.
- Incretin and metabolic peptide research: Extensively used in studies investigating incretin signaling and metabolic pathway interactions.
- Versatile research tool: Suitable for receptor binding, signaling studies, and comparative evaluations.
- Light-sensitive and storage-sensitive: Protect from light during handling.
- For research purposes only: Not for clinical, therapeutic, or diagnostic use.
How Tirzepatide (120 mg) Supports Research
Tirzepatide is a key tool in research focusing on receptor-driven metabolic signaling and cellular responses. It supports comparative assessments of peptide behavior in controlled models, helping researchers generate consistent results in receptor-binding assays and broader metabolic pathway research.
Research Applications & Usage Information
- Receptor binding assays: Evaluating receptor engagement and binding behavior in experimental setups.
- Signal transduction studies: Supporting the mapping of downstream signaling pathways in response to receptor activation.
- Metabolic research models: Used in research focusing on energy regulation and nutrient signaling pathways.
- Comparative peptide profiling: Serving as a reference material for evaluating peptide candidates and analogs.
- Method development: Assisting in the validation of assays and establishing experimental controls.
- Stability characterization: Used in studies evaluating peptide stability and handling conditions.
Handling and Storage Recommendations
- Minimize light exposure during handling; follow good laboratory practices.
- Follow good laboratory practices for handling to reduce contamination risk.
- Seal tightly to prevent moisture exposure.
- Track lot details to ensure proper documentation and storage history for research consistency.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Willard FS, Douros JD, Gabe MB, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020;5(17):e140532. Published 2020 Sep 3. doi:10.1172/jci.insight.140532
- Fisman EZ, Tenenbaum A. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect. Cardiovasc Diabetol. 2021;20(1):225. Published 2021 Nov 24. doi:10.1186/s12933-021-01412-5
- Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018;18:3-14. doi:10.1016/j.molmet.2018.09.009
What is Tirzepatide (120 mg)?
Tirzepatide is a synthetic peptide used in laboratory research to investigate metabolic signaling pathways related to nutrient response and energy regulation. It is often classified within incretin and metabolic peptide research due to its frequent use in models studying incretin-related receptor activity and downstream signaling mechanisms. In experimental settings, Tirzepatide is applied in receptor-binding studies, pathway analysis, and the comparative evaluation of peptide candidates.
Product Specifications
- Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum
- CAS Number: 2023788-19-2
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular Weight:4813.48 g/mol g/mol
- Peptide Sequence:
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ - Purity: ≥95% (verified by HPLC and mass spectrometry)
- Packaging Format: 120 mg lyophilized powder in a sealed research-grade vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long term). Protect from light.
- Intended Use: For Laboratory Research Use Only
Key Characteristics of Tirzepatide (120 mg)
- Defined peptide standard: Optimized for reproducible laboratory experiments and consistent results.
- High purity: ≥95%, minimizing variability in experimental outcomes.
- Incretin and metabolic peptide research: Extensively used in studies investigating incretin signaling and metabolic pathway interactions.
- Versatile research tool: Suitable for receptor binding, signaling studies, and comparative evaluations.
- Light-sensitive and storage-sensitive: Protect from light during handling.
- For research purposes only: Not for clinical, therapeutic, or diagnostic use.
How Tirzepatide (120 mg) Supports Research
Tirzepatide is a key tool in research focusing on receptor-driven metabolic signaling and cellular responses. It supports comparative assessments of peptide behavior in controlled models, helping researchers generate consistent results in receptor-binding assays and broader metabolic pathway research.
Research Applications & Usage Information
- Receptor binding assays: Evaluating receptor engagement and binding behavior in experimental setups.
- Signal transduction studies: Supporting the mapping of downstream signaling pathways in response to receptor activation.
- Metabolic research models: Used in research focusing on energy regulation and nutrient signaling pathways.
- Comparative peptide profiling: Serving as a reference material for evaluating peptide candidates and analogs.
- Method development: Assisting in the validation of assays and establishing experimental controls.
- Stability characterization: Used in studies evaluating peptide stability and handling conditions.
Handling and Storage Recommendations
- Minimize light exposure during handling; follow good laboratory practices.
- Follow good laboratory practices for handling to reduce contamination risk.
- Seal tightly to prevent moisture exposure.
- Track lot details to ensure proper documentation and storage history for research consistency.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Willard FS, Douros JD, Gabe MB, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020;5(17):e140532. Published 2020 Sep 3. doi:10.1172/jci.insight.140532
- Fisman EZ, Tenenbaum A. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect. Cardiovasc Diabetol. 2021;20(1):225. Published 2021 Nov 24. doi:10.1186/s12933-021-01412-5
- Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018;18:3-14. doi:10.1016/j.molmet.2018.09.009
Related products
